| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Viking Therapeutics, Inc. | Chief Commercial Officer | Stock Option (Right to Buy) | 180,000 | 12 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VKTX | Viking Therapeutics, Inc. | 12 Jan 2026 | 1 | $0 | 4 | Chief Commercial Officer | 26 Jan 2026, 19:57 |
| VKTX | Viking Therapeutics, Inc. | 12 Jan 2026 | 0 | $0 | 3 | Chief Commercial Officer | 26 Jan 2026, 19:55 |